Table 2 Clinical outcomes
Clinical outcomes | Unmatched cohort | Matched cohort | ||||
|---|---|---|---|---|---|---|
DKA (n = 1,150) | Non-DKA (n = 2413) | P-value | DKA (n = 1150) | Non-DKA (n = 2413) | P-value | |
Mortality | 68 (5.91%) | 25 (1.02%) | 0.012 | 64 (5.56%) | 29 (1.19%) | 0.024 |
Reinfarction | 70 (6.08%) | 31 (1.27%) | 0.019 | 67 (5.82%) | 35 (1.45%) | 0.021 |
Stroke | 43 (3.73%) | 22 (0.91%) | 0.038 | 51 (4.43%) | 33 (1.36%) | 0.035 |
Heart failure | 76 (6.6%) | 43 (1.78%) | 0.013 | 79 (6.89%) | 51 (2.11%) | 0.033 |
Cardiogenic shock | 74 (6.43%) | 41 (1.69%) | 0.017 | 74 (6.43%) | 43 (1.78%) | 0.025 |
Acute kidney injury | 275 (23.91%) | 132 (5.47%) | < 0.001 | 289 (25.13%) | 108 (4.47%) | < 0.001 |
Sepsis | 84 (7.3%) | 33 (1.36%) | 0.007 | 92 (8%) | 35 (1.45%) | 0.005 |
Mechanical ventilation | 102 (8.86%) | 44 (1.82%) | 0.006 | 109 (9.47%) | 52 (2.15%) | 0.003 |
Urinary tract infection | 174 (15.13%) | 57 (2.36%) | < 0.001 | 195 (16.95%) | 63 (2.61%) | < 0.001 |
Pneumonia | 81 (7.04%) | 57 (2.36%) | 0.005 | 83 (7.21%) | 56 (2.32%) | 0.004 |
Length of stay; mean ± SD | 9 ± 6 | 5 ± 4 | < 0.001 | 9 ± 5 | 5 ± 5 | < 0.001 |